OverviewChartNewsTraderScreen

DZ Bank Discount Zert GILD 27.09..../  DE000DJ8N698  /

Frankfurt Zert./DZB
11/06/2024  09:34:23 Chg.+0.090 Bid10:11:27 Ask- Underlying Strike price Expiration date Option type
59.380EUR +0.15% 59.490
Bid Size: 1,000		 -
Ask Size: -		 Gilead Sciences Inc - USD 27/09/2024 Call
GlobeNewswire 10/06 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 22/05 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 14/05 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 09/05 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 09/05 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 08/05 Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire 29/04 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...
GlobeNewswire 19/04 ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies...
GlobeNewswire 10/04 Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...
GlobeNewswire 03/04 Opthea Appoints Sujal Shah to the Board of Directors
GlobeNewswire 02/04 Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
GlobeNewswire 02/04 Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
GlobeNewswire 01/04 Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Fin...
GlobeNewswire 28/03 Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlight...
GlobeNewswire 28/03 Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
GlobeNewswire 28/03 Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
GlobeNewswire 22/03 HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire 18/03 CIO Celebrates Innovations in Business Technology with 2024 CIO 100 & Hall of Fame Awards
GlobeNewswire 11/03 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire 29/02 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CymaBay The...
GlobeNewswire 29/02 Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes J...
GlobeNewswire 28/02 CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corpo...
GlobeNewswire 27/02 MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
GlobeNewswire 24/02 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CBAY, IONM, WISH, FREE